Published by Iain Gilbert on 24th August 2026
(Sharecast News) - Drugmaker GSK notched two major regulatory milestones on Monday, with Japan granting the first global approval for its hepatitis B therapy Hibsago and US regulators accepting a priority review for Jemperli in previously untreated locally advanced rectal cancer.
URL: http://www.digitallook.com/dl/news/story/36161627/...